Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :

or

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :

or

Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Former Johnson & Johnson Exec. Added to CB2 Board

Stockhouse Editorial
1 Comment| July 31, 2019


CB2 Insights Inc. (CSE:CBII , Forum) announced on Wednesday that former Johnson & Johnson executive Peter Cummins has been named as a Director to its Board.

For more on this, click here.

CB2 was recently selected by Drug Science as the exclusive research technology platform for the UK's largest medical cannabis pilot project - TWENTY21. The project aims to enroll 20,000 patients and CB2 will build the patient registry sa well as generate real-world evidence throughout the program.


FULL DISCLOSURE: CB2 Insights Inc. is a client of Stockhouse Publishing.



Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Healthcare
Technology
Industrials
Metals & Mining

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.

Comments

Sugoioi
Add an organic fertilizer company in the heart of agriculture. Verde Agritech, NPK, is achieving steady growth and production as it develops towards its goal of 25million tons of fertilizer a year. Its currently cheap but as it proves itself the company stock has ALOT of leg room to run. If its resources in the ground can get valuation in the stock price, thats a potential $2billion towards 45million shares outstanding.
(9)
August 2, 2019

Leave a Comment

You must be logged in to access this feature.


×

StockTalk
Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.